Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 21, 2019
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameterTakaaki Izumi, Takuya Sho, Kenichi Morikawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 30, 2022
Overestimated renal function in patients with liver cirrhosis predicts poor prognosisSonoe Yoshida, Goki Suda, Masatsugu Ohara, et al.Cancers|January 11, 2022
Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular CarcinomaZijian Yang, Goki Suda, Osamu Maehara, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 22, 2023
Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weightYoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, et al.Scientific Reports|August 17, 2021
Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antiviralsYoshimasa Tokuchi, Goki Suda, Megumi Kimura, et al.Cancers|June 28, 2023
Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular CarcinomaRisako Kohya, Goki Suda, Masatsugu Ohara, et al.Targeted Oncology|September 2, 2024
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab TreatmentTakuya Sho, Goki Suda, Masatsugu Ohara, et al.Cancer Biology & Therapy|July 16, 2015
A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinomaOsamu Maehara, Fumiyuki Sato, Mitsuteru Natsuizaka, et al.Journal of Gastroenterology|March 20, 2017
Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapyGoki Suda, Koji Ogawa, Yoshiya Yamamoto, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2022
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver diseaseAkihisa Nakamura, Koji Yamamoto, Rei Takeda, et al.Pageof 15